Skip to main content
Top
Published in: CEN Case Reports 1/2014

01-05-2014 | Case Report

Periodic hypokalemia associated with cyclic Cushing’s syndrome

Authors: Hiroaki Kikuchi, Takanobu Yoshimoto, Hiroyuki Tanaka, Kazutaka Tsujimoto, Chisato Yamamura, Yohei Arai, Suguru Hirasawa, Shota Aki, Naoto Inaba, Makoto Aoyagi, Yoshihiro Ogawa, Teiichi Tamura

Published in: CEN Case Reports | Issue 1/2014

Login to get access

Abstract

A 69-year-old woman presented with periodic hypertension, edema, and hypokalemia that occurred within an interval of a few weeks. Her laboratory test values showed autonomously elevated plasma adrenocorticotropic hormone (ACTH) and cortisol concentrations. The patient’s Cushingoid features were not evident on first admission. Several weeks later, in spite of constant oral potassium supplementation, severe hypokalemia recurred with Cushingoid features and worsening symptoms of leg edema and pigmentation, which spontaneously disappeared within a few days. Her periodic symptoms occurred in parallel with fluctuations of plasma ACTH and cortisol concentrations. A series of endocrinological and pituitary imaging findings led to a tentative diagnosis of cyclic Cushing’s syndrome caused by ectopic ACTH secretion. However, chest and abdominal computed tomography did not reveal any candidate lesion. The patient’s periodic hypercortisolemia and symptoms were well controlled after treatment with metyrapone plus dexamethasone. This is a very rare case of periodic hypokalemia and hypertension caused by cyclic Cushing’s syndrome.
Literature
1.
go back to reference Handler J. Cushing’s syndrome with uncontrolled hypertension, occasional hypokalemia, and two pregnancies. J Clin Hypertens (Greenwich). 2010;12:516–21. Handler J. Cushing’s syndrome with uncontrolled hypertension, occasional hypokalemia, and two pregnancies. J Clin Hypertens (Greenwich). 2010;12:516–21.
2.
go back to reference Meinardi JR, Wolffenbuttel BH, Dullaart RP. Cyclic Cushing’s syndrome: a clinical challenge. Eur J Endocrinol. 2007;157:245–54.PubMedCrossRef Meinardi JR, Wolffenbuttel BH, Dullaart RP. Cyclic Cushing’s syndrome: a clinical challenge. Eur J Endocrinol. 2007;157:245–54.PubMedCrossRef
3.
go back to reference Atkinson AB, Kennedy AL, Carson DJ, Hadden DR, Weaver JA, Sheridan B. Five cases of cyclical Cushing’s syndrome. Br Med J (Clin Res Ed). 1985;291:1453–7.CrossRef Atkinson AB, Kennedy AL, Carson DJ, Hadden DR, Weaver JA, Sheridan B. Five cases of cyclical Cushing’s syndrome. Br Med J (Clin Res Ed). 1985;291:1453–7.CrossRef
4.
go back to reference Brown RD, Van Loon GR, Orth DN, Liddle GW. Cushing’s disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab. 1973;36:445–51.PubMedCrossRef Brown RD, Van Loon GR, Orth DN, Liddle GW. Cushing’s disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab. 1973;36:445–51.PubMedCrossRef
5.
go back to reference Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15:309–15.PubMed Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15:309–15.PubMed
6.
go back to reference Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19:424–6.PubMedCrossRef Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19:424–6.PubMedCrossRef
7.
go back to reference Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev. 1998;19:647–72.PubMed Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev. 1998;19:647–72.PubMed
8.
go back to reference Doi M, Sugiyama T, Izumiyama H, Yoshimoto T, Hirata Y. Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. Endocr J. 2010;57:1061–9.PubMedCrossRef Doi M, Sugiyama T, Izumiyama H, Yoshimoto T, Hirata Y. Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. Endocr J. 2010;57:1061–9.PubMedCrossRef
9.
go back to reference Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, et al. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1999;84:487–92.PubMed Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, et al. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1999;84:487–92.PubMed
10.
go back to reference Graham KE, Samuels MH, Nesbit GM, Cook DM, O’Neill OR, Barnwell SL, Loriaux DL. Cavernous sinus sampling is highly accurate in distinguishing Cushing’s disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J Clin Endocrinol Metab. 1999;84:1602–10.PubMed Graham KE, Samuels MH, Nesbit GM, Cook DM, O’Neill OR, Barnwell SL, Loriaux DL. Cavernous sinus sampling is highly accurate in distinguishing Cushing’s disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J Clin Endocrinol Metab. 1999;84:1602–10.PubMed
11.
go back to reference Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med. 1991;325:897–905.PubMedCrossRef Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med. 1991;325:897–905.PubMedCrossRef
12.
go back to reference Sakai Y, Horiba N, Tozawa F, Sakai K, Kuwayama A, Demura H, Suda T. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing’s syndrome. Endocr J. 1997;44:687–95.PubMedCrossRef Sakai Y, Horiba N, Tozawa F, Sakai K, Kuwayama A, Demura H, Suda T. Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing’s syndrome. Endocr J. 1997;44:687–95.PubMedCrossRef
13.
go back to reference Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: 20 years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955–62.PubMedCrossRef Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: 20 years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955–62.PubMedCrossRef
14.
go back to reference Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev. 1994;15:752–87.PubMed Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev. 1994;15:752–87.PubMed
Metadata
Title
Periodic hypokalemia associated with cyclic Cushing’s syndrome
Authors
Hiroaki Kikuchi
Takanobu Yoshimoto
Hiroyuki Tanaka
Kazutaka Tsujimoto
Chisato Yamamura
Yohei Arai
Suguru Hirasawa
Shota Aki
Naoto Inaba
Makoto Aoyagi
Yoshihiro Ogawa
Teiichi Tamura
Publication date
01-05-2014
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2014
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-013-0090-1

Other articles of this Issue 1/2014

CEN Case Reports 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.